Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 3911-3914

  Parker, S P ^a,b   Quinlivan, M ^a   Taha, Y ^a,c   Breuer, J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Murex Biotech Ltd   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE; VIRUS DNA;

ADULT; ARTICLE; CHICKENPOX; GENOTYPE; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; REAL TIME POLYMERASE CHAIN REACTION; STRAIN IDENTIFICATION; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS DETECTION;

CHICKENPOX VACCINE; GENOTYPE; HERPESVIRUS 3, HUMAN; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 33750950868     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00346-06     Document Type: Article

References (19)

1. Barrett-Muir, W., R. A. Nichols, and J. Breuer. 2002. Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J. Virol. 76:1971-1979.
2. Breuer, J. 2004. Varicella zoster virus, p53-83. In A. J. Zuckerman, J. E. Banatvala, J. R. Pattison, P. D. Griffiths, and B. D. Schoub (ed.), Principles and practice of clinical virology, 5th edition. John Wiley, Chichester, United Kingdom.
3. Campsall, P. A., N. H. Au, J. S. Prendiville, D. P. Speert, R. Tan, and E. E. Thomas. 2004. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J. Clin. Microbiol. 42:1409-1413.
4. Centers for Disease Control and Prevention. 1996. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 45:1-25.
5. Faga, B., W. Maury, D. A. Bruckner, and C. Grosse. 2001. Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology 280:1-6.
6. Gershon, A. A. 1995. Varicella-zoster virus: Prospects for control. Adv. Fed. Infect. Dis. 10:93-123.
7. Gomi, Y., T. Magana, M. Takahashi, and K. Yamanishi. 2000. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J. Med. Virol. 61:497-503.
8. Hawrami, K., and J. Breuer. 1999. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of VZV. J. Virol. Methods 79:33-40.
9. Klein, D. 2002. Quantification using real-time PCR technology: applications and limitations. Trends Mol. Med. 8:257-260.
10. LaRussa, P., O. Lungu, I. Hardy, A. Gershon, S. P. Steinberg, and S. Silverstein. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J. Virol. 66:1016-1020.
11. Lee, B. R., S. L. Feaver, C. A. Miller, C. W. Hedberg, and K. R. Ehresmann. 1996. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J. Infect. Dis. 190:477-483.
12. Loparev, V. N., T. Agra, P. R. Krause, M. Takeaway, and D. S. Schmidt. 2000. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol. 38:3156-3160.
13. Loparev, V. N., A. Gonzalez, M. Deleon-Carnes, G. Tipples, H. Fickenscher, E. G. Torfason, and D. S. Schmid. 2004. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol. 78:8349-8358.
14. Quinlivan, M. L., A. A. Gershon, S. P. Steinberg, and J. Breuer. 2005. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J. Med. Virol. 75:174-180.
15. Sharrar, R. G., P. LaRussa, S. A. Galea, S. P. Steinberg, A. R. Sweet, R. M. Keatley, M. E. Wells, W. P. Stephenson, and A. A. Gershon. 2000. The postmarketing safety profile of varicella vaccine. Vaccine 19:916-923.
16. Takada, M., T. Suzutani, I. Yoshida, M. Matoba, and M. Azuma. 1995. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J. Clin. Microbiol. 33:658-660.
17. Tipples, G. A., D. Safronetz, and M. Gray. 2003. Real-time PCR assay for the detection of varicella-zoster virus DNA and differentiation of vaccine, wildtype and control strains. J. Virol. Methods. 113:113-116.
18. Wagenaar, T., V. T. K. Chow, C. Buranathai, P. Thawatsupha, and C. Grose. 2003. The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072-1081.
19. Weibel, R. E., B. J. Neff, B. J. Kuter, H. A. Guess, C. A. Rothenberger, A. J. Fitzgerald, K. A. Connor, A. A. McLean, M. R. Hilleman, and E. B. Buynak. 1984. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N. Engl. J. Med. 310:1409-1411.